Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition
type: MedicalStudy
description: Monocenter, Open-label, Randomized Study to Determine the Ovulation Inhibitory Effect of the Combined Oral Contraceptive SH T04769G and SH D00659AF (0.03 mg Ethinylestradiol and 2.0 mg Dienogest), Applied for Two Treatment Cycles to 60 Healthy Female Volunteers
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2007-04
end date: 2007-12
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00471991
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Bayer
study subject: Oral Contraceptive
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Oral Contraceptive

AI Analytics
type: Organization